secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emergent BioSolutions Inc. (EBS)
CIK:        0001367644
Form:       8-K
Filed at:   2023-11-24T23:59:59+00:00
Accession:  0001367644-23-000195
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emergent BioSolutions receives NYSE delisting notice for delayed Q3 10-Q filing
-------------------------------------------------------------------------------

- NYSE notified Emergent of noncompliance on Nov 16, 2023 due to late Q3 10-Q.
- Company has six months from Nov 9, 2023 to file the 10-Q and regain compliance.
- Delay stems from evaluating state deferred tax liability adjustments affecting prior periods.
- No Q3 financial results provided; company still assessing impact of adjustments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367644/000136764423000195/0001367644-23-000195-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367644/000136764423000195/ebs-20231116.htm
  HTML page:      https://secwatch.observer/filing/0001367644-23-000195

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer